The prevalence of the coronavirus disease 2019 (COVID-19) pandemic in its second year
has led to massive global human and economic losses. The high transmission rate and the …

The production of pharmaceutical compounds in plants is attracting increasing attention, as
plant-based systems can be less expensive, safer, and more scalable than mammalian …

Molecular farming of vaccines has been heralded as a cheap, safe and scalable production
platform. In reality, however, differences in the plant biosynthetic machinery, compared to …

Plant-based heterologous expression systems can be leveraged to produce high-value
therapeutics, industrially important proteins, metabolites, and bioproducts. The production …

The COVID-19 pandemic, caused by the worldwide spread of SARS-CoV-2, has prompted
the scientific community to rapidly develop efficient and specific diagnostics and …

The current COVID-19 pandemic very dramatically shows that the world lacks preparedness
for novel viral diseases. In addition to newly emerging viruses, many known pathogenic …

Capsid protein of Hepatitis E virus (HEV) is capable of self-assembly into virus-like particles
(VLPs) when expressed in Nicotiana benthamiana plants. Such VLPs could be used as …

The outbreak of the SARS-CoV-2 global pandemic heightened the pace of vaccine
development with various vaccines being approved for human use in a span of 24 months …

The COVID-19 pandemic has underscored the need for rapid and cost-effective diagnostic
tools. Serological tests, particularly those measuring antibodies targeting the receptor …

Emerging and re-emerging zoonotic diseases cause serious illness with billions of cases,
and millions of deaths. The most effective way to restrict the spread of zoonotic viruses …